参考文献/References:
[1].onikowski P,Voors AA,Anker SD,et al.2016?ESC?Guidelines?for the?diagnosis?and?treatment?of?acute?and?chronic heart failure:The Task Force for the?diagnosis?and?treatment?of?acute?and?chronic heart failure?of the European Society of Cardiology (ESC)Developed with the special contribution of the?Heart Failure?Association (HFA) of the?ESC[J].Eur Heart J,2016,37(27):2129-2200.
[2].Zile MR, Gottdiener JS, Hetzel SJ, et al. Prevalence and significance of alterations in cardiac structure and function in patients with heart failure and a preserved ejection fraction[J]. Circulation,2011,124(23):2491-2501.
[3].Atherton JJ,Sindone A,de Pasquale CG,et al.National heart foundation of Australia and Cardiac Society of Australia and New Zealand:Guidelines for the prevention, detection, and management of heart failure in Australia 2018[J].Heart Lung Circ, 2018,27(10):1123-1208.
[4].[4] Shah AM,Shah SJ,Anand IS,et al.Cardiac structure and function in heart failure with preserved ejection fraction:baseline findings from the echocardiographic study of the treatment of preserved cardiac function heart failure with an aldosterone antagonist trial[J].Circ Heart fail,2014,7(1):104-115.
[5].[5] Miljkovik LV,Spiroska V.Heart failure with preserved ejection fraction—concept,pathophysiology,diagnosis and challenges for treatment[J].Open Access Maced J Med Sci,2015,3(3):521-527.
[6].[6]Lupu S,Mitre A,Dobreanu D.Left atrium function assessment by echocardiography – physiological and clinical implications[J].Med Ultrason,2014,16(2):152-159.
[7].[7]Pieske B,Tschope C,de Boer RA,et al.How to?diagnose?heart failure?with?preserved?ejection?fraction: the?HFA-PEFF?diagnostic?algorithm: a consensus recommendation from the?Heart Failure?Association (HFA) of the European Society of Cardiology (ESC)[J]. Eur?Heart?J,2019,40(40):3297-3317.
[8].[8]Cameli M, Lisi M, Mondillo S, et al. Left atrial longitudinal strain by speckle tracking echocardiography correlates well with left ventricular filling pressures in patients with heart failure[J].Cardiovasc Ultrasound,2010, 8:14.
[9].[9]Reddy YNV,Obokata M,Egbe A,et al.Left atrial strain and compliance in the diagnostic evaluation of heart failure with preserved ejection fraction[J].Eur J Heart Fail,2019,21(7):891-900.
[10].[10] Telles F,Nanayakkara S,Evans S,et al.Impaired left atrial strain predicts abnormal exercise haemodynamics in heart failure with preserved ejection fraction[J].Eur J Heart Fail,2019,21(4):495-505.
[11].[11]Freed BH,Daruwalla V,Cheng JY,et al.Prognostic?utility?and?clinical?significance?of?cardiac?mechanics?in?heart?failure?with?preserved ejection?fraction: importance?of?left?atrial?strain[J].Circ Cardiovasc Imaging, 2016,9(3).:10.1161/CIRCIMAGING.115.003754 e003754.
[12].[12]Santos AB, Kraigher-Krainer E, Gupta DK,et al.Impaired left atrial function in heart failure with preserved ejection fraction[J].Eur J Heart Fail 2014;16:1096-1103.
[13].[13]任小田孙磊.射血分数保留的心力衰竭的研究进展[J]心血管病学进展2018,39(6):987-990.
[14].[14]Persson H, Lonn E, Edner M. Diastolic dysfunction in heart failure with preserved systolic function: need for objective evidence:results from the CHARM Echocardiographic Substudy-CHARMES[J].J Am Coll Cardiol,2007,49(6):687-694.
[15].[15]Nagueh?SF,Smiseth?OA,Appleton?CP,et?al.Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging[J].J Am Soc Echocardiogr,2016,29(4):277-314.
[16].[16]Morris DA,Belyavskiy E,Aravind-Kumar R.Potential usefulness and clinical relevance of adding left atrial strain to left atrial volume index in the detection of left ventricular diastolic dysfunction[J].JACC Cardiovasc Imaging,2018;11(10):1405-1415.
相似文献/References:
[1]丁娟,刘地川.心力衰竭与线粒体功能障碍的研究进展[J].心血管病学进展,2016,(1):84.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.022]
DING Juan,LIU Dichuan.Research Progress of Heart Failure and Mitochondrial Dysfunction[J].Advances in Cardiovascular Diseases,2016,(6):84.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.022]
[2]罗秀林,综述,张烁,等.肾动脉去交感神经术治疗心力衰竭——希望还是炒作[J].心血管病学进展,2016,(3):268.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.013]
LUO Xiulin,ZHANG Shuo.Renal Sympathetic Denervation for Heart Failure—Hopes or Hypes[J].Advances in Cardiovascular Diseases,2016,(6):268.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.013]
[3]查凤艳,综述,覃数,等.心源性恶病质发病机制的研究进展[J].心血管病学进展,2016,(3):282.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.017]
ZHA Fengyan,QIN Shu.Advances in Pathogenesis of Cardiac Cachexia[J].Advances in Cardiovascular Diseases,2016,(6):282.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.017]
[4]李慧,综述,齐国先,等.老年射血分数保留的心功能不全研究进展[J].心血管病学进展,2016,(4):354.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.007]
LI Hui,QI Guoxian.Research Progress of Heart Failure with Preserved Ejection Fraction in Elderly People[J].Advances in Cardiovascular Diseases,2016,(6):354.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.007]
[5]亢玉,综述,张庆,等.二尖瓣瓣叶在功能性二尖瓣反流发生机制中的角色[J].心血管病学进展,2016,(4):376.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.013]
KANG Yu,ZHANG Qing.Role of Mitral Leaflets in Pathogenesis of Functional Mitral Regurgitation[J].Advances in Cardiovascular Diseases,2016,(6):376.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.013]
[6]史秀莉,张庆,喻鹏铭.心力衰竭患者运动训练方式及其疗效的研究进展[J].心血管病学进展,2015,(5):535.[doi:10.3969/j.issn.1004-3934.2015.05.003]
SHI Xiuli,ZHANG Qing,YU Pengming.Exercise Training Modalities and Their Treatment Effects on
Patients with Heart Failure[J].Advances in Cardiovascular Diseases,2015,(6):535.[doi:10.3969/j.issn.1004-3934.2015.05.003]
[7]熊卓超,陈康玉,严激.无创血流动力学评价在心力衰竭中的应用进展[J].心血管病学进展,2019,(6):923.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.021]
XIONG Zhuochao,CHEN Kangyu,YAN Ji.Application Progress of Noninvasive Hemodynamic Evaluation in Heart Failure[J].Advances in Cardiovascular Diseases,2019,(6):923.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.021]
[8]高薇 陈伟.铁过载性心肌病[J].心血管病学进展,2019,(5):680.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.006]
GAO WeiCHEN Wei.Iron Overload Cardiomyopathy[J].Advances in Cardiovascular Diseases,2019,(6):680.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.006]
[9]何燕 刘育.C型利钠肽与心力衰竭[J].心血管病学进展,2019,(5):745.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.020]
HE Yan,LIU Yu.C-type Natriuretic Peptide and Heart Failure[J].Advances in Cardiovascular Diseases,2019,(6):745.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.020]
[10]吴彤 高东来.心房颤动合并心力衰竭的射频消融治疗[J].心血管病学进展,2019,(5):757.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.023]
WU TongGAO Donglai.Catheter Ablation of Atrial Fibrillation in Patients with Heart Failure[J].Advances in Cardiovascular Diseases,2019,(6):757.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.023]